Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia
Blood and Lymphatic Cancer: Targets and Therapy · 2026-07 · Volume 16 · 1-15
DOI: 10.2147/blctt.s621412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2026-07. Verfasst von Zixing Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People's Republic of Chi…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People's Republic of China.
- Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People's Republic of China.
- Department of Hematology, Ningbo Medical Centre Lihuili Hospital, Ningbo, Zhejiang, People's Republic of China.
Zitieren
APA
Lu, Z., Liu, Y., Jiang, Z., Zhu, Y., Liu, W., Sun, Q., Fan, L., Qian, S., & Hong, M. (2026). Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia. Blood and Lymphatic Cancer: Targets and Therapy, Volume 16, 1-15. https://doi.org/10.2147/blctt.s621412
Vancouver
Lu Z, Liu Y, Jiang Z, Zhu Y, Liu W, Sun Q, et al. Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia. Blood and Lymphatic Cancer: Targets and Therapy. 2026;Volume 16:1-15. doi:10.2147/blctt.s621412
BibTeX
@article{Lu2026,
author = {Lu, Zixing and Liu, Yayi and Jiang, Zhaoqing and Zhu, Yu and Liu, Wenjie and Sun, Qian and Fan, Lei and Qian, Sixuan and Hong, Ming},
title = {Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 16},
pages = {1--15},
doi = {10.2147/blctt.s621412}
}
EUVIMED